Myrbetriq, known generically as mirabegron, does not currently have an approved generic version available in the United States [1].
When might a generic version become available?
The patent exclusivity for Myrbetriq is set to expire. According to DrugPatentWatch.com, the earliest possible patent expiry date for mirabegron is in 2025 [2]. This date can be subject to various factors, including patent litigation and any potential extensions.
What are the key components of Myrbetriq?
Myrbetriq is a medication containing mirabegron as its active ingredient [1]. Mirabegron functions as a beta-3 adrenergic agonist, which works by relaxing the bladder muscle, increasing bladder capacity [3].
What is Myrbetriq used to treat?
Myrbetriq is prescribed to treat overactive bladder (OAB) with or without urinary incontinence, urgency, and frequency symptoms in adults [3].
What are the risks associated with Myrbetriq?
Common side effects reported with Myrbetriq include high blood pressure, nasopharyngitis (common cold symptoms), urinary tract infections, and constipation [3]. It is important for patients to discuss their full medical history with their doctor to assess potential risks.
How does Myrbetriq compare to other OAB treatments?
Myrbetriq offers an alternative mechanism of action for OAB compared to anticholinergic medications. While anticholinergics work by blocking acetylcholine, mirabegron relaxes the detrusor muscle. This difference can be significant for patients who do not tolerate anticholinergics or who do not achieve adequate symptom relief with them [3].
What is the current pricing of Myrbetriq?
As Myrbetriq is a branded medication without generic alternatives, its pricing is set by the manufacturer. Actual costs can vary depending on insurance coverage, pharmacy, and dosage. Information on current pricing is typically available through pharmaceutical company websites or by consulting with a pharmacist [1].
Sources
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. Manufacturer's Prescribing Information for Myrbetriq